Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000418704 | SCV000524764 | likely pathogenic | not provided | 2024-12-26 | criteria provided, single submitter | clinical testing | Observed with a pathogenic variant on the opposite allele (in trans) in a patient with ALG8-related congenital disorder of glycosylation (CDG Ih) referred for genetic testing at GeneDx and subsequently included in the published literature (PMID: 35716054); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 35716054) |
Eurofins Ntd Llc |
RCV000418704 | SCV000705914 | uncertain significance | not provided | 2017-03-16 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005004155 | SCV005631777 | likely pathogenic | ALG8 congenital disorder of glycosylation; Polycystic liver disease 3 with or without kidney cysts | 2024-06-03 | criteria provided, single submitter | clinical testing |